Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human liver catechol-O-methyltransferase pharmacogenetics.

B Boudíková1, C Szumlanski, B Maidak

  • 1Department of Pharmacology, Mayo Clinic, Rochester, MN 55905.

Clinical Pharmacology and Therapeutics
|October 1, 1990
PubMed
Summary

A common genetic polymorphism influences catechol-O-methyltransferase (COMT) activity and stability in red blood cells and the liver. This genetic variation affects enzyme properties in both tissues, impacting drug metabolism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

Translational psychiatry·2016
Same author

Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.

Clinical pharmacology and therapeutics·2016
Same author

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

Translational psychiatry·2015
Same author

Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.

Clinical pharmacology and therapeutics·2015
Same author

Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.

Leukemia·2008
Same author

Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.

Oncogene·2006

Area of Science:

  • Pharmacogenetics
  • Biochemistry
  • Human Genetics

Background:

  • Catechol-O-methyltransferase (COMT) is crucial for metabolizing catecholamines.
  • A known genetic polymorphism affects COMT activity and thermal stability in human red blood cells.
  • This polymorphism is present in 25-30% of the population, leading to low enzyme activity and thermolability.

Purpose of the Study:

  • To investigate if the same genetic polymorphism controlling red blood cell COMT also influences COMT in the human liver.
  • To determine the prevalence of thermolabile COMT in liver tissue.
  • To examine sex-based differences in hepatic COMT activity and stability.

Main Methods:

  • Hepatic biopsy samples (n=99) were analyzed for COMT enzyme activity and thermal stability.

Related Experiment Videos

  • Enzyme thermal stability was assessed using heated/control ratios.
  • COMT activity and stability were correlated with sex and red blood cell enzyme characteristics.

    • Main Results:

    • 28% of liver samples exhibited thermolabile COMT.
    • Male subjects had significantly higher hepatic COMT activity than female subjects.
    • A significant correlation was found between COMT activity and thermal stability in both sexes.
    • Red blood cell COMT properties correlated with hepatic COMT activity and stability.

    Conclusions:

    • The genetic polymorphism affecting red blood cell COMT also influences COMT activity and thermal stability in the human liver.
    • This suggests a systemic genetic control over COMT enzyme characteristics across different human tissues.
    • Findings have implications for understanding individual variability in drug metabolism and catecholamine signaling.